Adverse Event Profiles

FDA adverse event reports (FAERS) include all outcomes reported during treatment and do not establish causation. Report counts reflect all approved indications for each drug, not only this disease.

4,283 adverse event reports have been filed with the FDA for NITRIC OXIDE (across all indications). Most commonly reported: atrial fibrillation, candida pneumonia, and drug effect incomplete.

Gene therapy approaches for pulmonary hypertension, neonatal have been reported in the published literature.

Disease patterns and progression

Recent Publications

• Homedi A (2026). [PMID: 41628967](https://pubmed.ncbi.nlm.nih.gov/41628967/). *Saudi Med J*. [Clinical Trial Publication]

• Mooers EA (2026). [PMID: 42276722](https://pubmed.ncbi.nlm.nih.gov/42276722/). *Clin Perinatol*. [Review / Meta-Analysis]

• Isaac Maximo LM (2026). [PMID: 41911150](https://pubmed.ncbi.nlm.nih.gov/41911150/). *Neonatology*. [Review / Meta-Analysis]

• Nakanishi H (2026). [PMID: 41116023](https://pubmed.ncbi.nlm.nih.gov/41116023/). *Pediatr Res*. [Review / Meta-Analysis]

• Pantoja-Gomez OC (2026). [PMID: 40645815](https://pubmed.ncbi.nlm.nih.gov/40645815/). *Paediatr Respir Rev*. [Review / Meta-Analysis]

• Sánchez-Moreira M (2026). [PMID: 41530743](https://pubmed.ncbi.nlm.nih.gov/41530743/). *BMC Pregnancy Childbirth*. [Epidemiology / Natural History]

• Jenkinson A (2026). [PMID: 40523948](https://pubmed.ncbi.nlm.nih.gov/40523948/). *Pediatr Res*. [Epidemiology / Natural History]

• Chen N (2026). [PMID: 41318102](https://pubmed.ncbi.nlm.nih.gov/41318102/). *Biochemical pharmacology*. [Review / Meta-Analysis]

• Nandula PS (2026). [PMID: 36256747](https://pubmed.ncbi.nlm.nih.gov/36256747/). *Unknown Journal*. [Review / Meta-Analysis]

• Ambalavanan N (2026). [PMID: 40880213](https://pubmed.ncbi.nlm.nih.gov/40880213/). *Physiological reviews*. [Review / Meta-Analysis]